Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oleogel-S10 in inherited epidermolysis bullosa
RBR-4vz9c4Phase 3Not yet recruiting
- Sponsor
- Hospital da Criança Santo Antônio
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in epidermolysis bullosa (EB) comparing Oleogel-S10 topical with Placebo vehicle topical (2 arms). Planned start Mar 2018; status: not yet recruiting.
02
Drugs
Birch bark extract
03
Conditions
epidermolysis bullosa (EB)
Beyond the preview
Go deeper on RBR-4vz9c4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4vz9c4.